May 10, 2025 - 06:09

In a recent episode of the podcast, Dr. Ted Wright, a renowned cardiothoracic surgeon, delves into the innovative approach of Hybrid Afib Therapy. This cutting-edge treatment combines surgical and catheter-based techniques to address atrial fibrillation, a common heart rhythm disorder that affects millions worldwide.
Dr. Wright discusses the complexities of Afib and the challenges patients face when seeking effective treatment options. He explains how Hybrid Afib Therapy offers a comprehensive solution by integrating both surgical and minimally invasive methods, potentially leading to better outcomes for patients.
Listeners will gain insight into the procedural aspects of the therapy, the benefits it provides, and the importance of individualized treatment plans. Dr. Wright also emphasizes the role of patient education and shared decision-making in achieving optimal results. This episode serves as a valuable resource for anyone looking to understand more about advancements in cardiac care and the future of Afib treatments.
August 26, 2026 - 02:33
Faulkner University Awarded More Than $3 Million to Transform Rural Health Care Access and Workforce Development in AlabamaFaulkner University has secured more than $3 million in funding through Alabama`s Rural Health Transformation Program to expand medical services and train a new generation of health care workers...
August 25, 2026 - 13:39
Drug mix-up at Ascension impacts at least 4 surgeries, leaves 1 patient paralyzedHospital officials are working to determine how a contaminated anesthetic may have reached operating rooms, after at least four joint replacement procedures were impacted and one patient was left...
August 24, 2026 - 17:16
Alfalfa sprouts linked to food poisoning in 15 states, officials sayFederal health authorities have identified alfalfa sprouts as the likely source of a multi-state food poisoning outbreak that has now reached 15 states. The Centers for Disease Control and...
August 24, 2026 - 15:42
FDA digital health leader promises generative AI regulatory guidance is comingThe U.S. Food and Drug Administration is preparing to release formal guidance on how it will regulate generative artificial intelligence used in medical devices, according to Rick Abramson, the...